Organogenesis Holdings Inc
NASDAQ:ORGO
Organogenesis Holdings Inc
NASDAQ:ORGO
Price:
2.68 USD
1.13%
Market Closed
Updated:
Jun 7, 2024
Organogenesis Holdings Inc
Net Income (Common)
|
Organogenesis Holdings Inc
Net Income (Common) Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Organogenesis Holdings Inc
NASDAQ:ORGO
|
Net Income (Common)
$5.8m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Net Income (Common)
$6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
4%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Net Income (Common)
$484m
|
CAGR 3-Years
17%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-20%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Net Income (Common)
$3.8B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-2%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Net Income (Common)
$4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Net Income (Common)
$3.9B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
10%
|
CAGR 10-Years
26%
|
See Also
What is Organogenesis Holdings Inc's Net Income (Common)?
Net Income (Common)
5.8m
USD
5.8m
USD
Based on the financial report for Mar 31, 2024, Organogenesis Holdings Inc's Net Income (Common) amounts to 5.8m USD.
What is Organogenesis Holdings Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
-49%
-49%
Over the last year, the Net Income (Common) growth was -56%. The average annual Net Income (Common) growth rates for Organogenesis Holdings Inc have been -49% over the past three years .
You don't have any saved screeners yet
